’60s
behind enemy lines, including kamikaze attacks, brain surgery without anesthesia and two typhoons. Oliver returned to his alma mater after the war and served as a Pitt surgery professor from 1945 to 1955. Stewart would graduate from Pitt Med a few years later and go on to uncover surprising discoveries with stem cells. In 2007, one of his papers was cited as a Scientific Landmark in Cancer Research by the American Association for Cancer Research.
’80s
witness, an experience he calls “a privilege.” Zimmet—the owner and director of Zimmet Vein & Dermatology in Austin, Texas—worked with the DoJ for nearly 300 hours on the case, for which the defendant was found guilty. “While the vast majority of physicians are dedicated and caring,” he says, “we also know there is significant fraud and abuse going on. It doesn’t serve us, our field or society well.”
Our Broken Government and the Plight of Veterans,” was published in October. Shulkin is the Distinguished Health Policy Fellow at the University of Pennsylvania’s Leonard Davis Institute of Health Economics and president of Shulkin Solutions, which partners with health care and veterans organizations. “Veterans deserve the best care available in this country,” he notes.
’90s
training” in skills like delivering bad news and speaking with empathy. So he helped to create the Humanism Project, which teaches residents communication skills, biomedical ethics and self-care—“the forgotten part of medical education,” he says. Wolf hasn’t forgotten the funny bone, either: He’s exploring the benefits of using humor to teach medical students and residents. His team presented a workshop on the topic at the 2019 Southern Group on Educational Affairs regional conference.
Navy preventive medicine officer, focusing on the treatment and prevention of service-related infectious diseases, has included tours in Japan, Denmark, Cambodia and Iraq—granting him “great professional satisfaction.” He’s also served in Europe with the WHO. From 2014–2017, Faix was the principal investigator of the Millennium Cohort Study, the largest-ever prospective cohort study of military personnel, with more than 200,000 participants; it examines “the health effects,” says Faix, “of military-unique exposures such as deployment and combat.”’00s
She oversees a team of researchers investigating Alzheimer’s disease, Down syndrome (DS) and the relationship between the two, among other areas. “Individuals with DS,” Cohen notes, “almost universally have Alzheimer’s pathology by midlife.” Her recently published research indicates that the brain areas where people with DS first develop Alzheimer’s pathology are different than those in neurotypical brains—a discovery, she says, that “will be very meaningful for clinical trials” working to prevent Alzheimer’s in DS patients.
patients anywhere. Baca’s lab uses a 3D printer to create wearable patches. Those patches have tiny needles for collecting fluid from between cells and could help diagnose and treat high blood pressure and infections. Baca is part of an international project using AI and machine learning to improve point-of-care testing in developing areas for cancer and Zika virus, as well as other conditions. He says their next question is: “How do we integrate the big data?” 
Umamaheswar Duvvuri (Otolaryngology Resident ’07) serves as associate professor of otolaryngology at Pitt; he’s also the Department of Otolaryngology’s director of robotic surgery and holds an additional appointment at the VA Pittsburgh Healthcare System. His department performs about 100 robot-assisted ear, nose and throat surgeries per year. As the medical director for Pittsburgh CREATES, Duvvuri helps connect surgeons with engineers and companies to further bioengineering innovation.’10s
in St. Louis. He’s also chief medical officer for BJC Home Care. In these roles, White helps to train future palliative care doctors. “I fell in love with the field,” he says, “doing house calls with my father, who was a community pulmonologist. I was always in awe of how gracious the patients and families were.”
Nina Sabins (PhD ’13) was recently promoted to associate director at Janssen Pharmaceutical Companies of Johnson & Johnson, where she works to develop novel strategies to measure biomarkers—strategies that can lead to earlier, faster decision-making in the clinical environment. Her research publications, three of which she published while at Janssen, also focus on cancer immunology and immunotherapy—“proof,” she says, with a chuckle, “that you can publish in industry.” Why translational science? The field, Sabins notes, “is at the interface between the bench and the clinic,” giving Sabins the opportunity, ultimately, to help create “better drugs for patients.”